Mammalian homolog HsMAD2L1 HsCCNE1 HsMAPKAPK2 HsSLC29A1 HsBAF53A HsFK506-bp1 HsTMSB4X HsDUT HsEEF1G HsIARS HsIPO7 HsSCYE1 HsBUB3 MmMYB HsCCT4 HsCDC2 HsLMNB1 MmFATP HsCCNK HsHARS HsASH2L HsMetAP2 HsSRPR HsNotch2 HsTTC4 HsNOP5/NOP58 HsEGR1 HsPRDX4 HsNUP98 HsDDX5 HsCDC20 HsTGFBI HsNAB1 HsHSPB2 HsRFC4 HsRAN HsEEF1A1 MmNr2f1 HsERCC1 HsCSNK2B HsGSTT1 HsMINPP1 HsSNRPF HsRRM2 HsSNRPD3 HsMCM3 HsPLK HsCCNA1 HsMCM2 HsKIF11 Reference [1] [2, 3] [4, 5] [6] [7] [8] [9] [10] [11] [12] [13] [14, 15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27, 28] [29] [30] [31, 32] [33] [34] [35] [36] [37] [38] [39, 40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [49] [51] [52] [19, 52-56] [19, 51, 57] [58, 59] HsPCNA HsSKP2 HsFBL HsCDC25B HsCCNB1 HsCDK7 HsEEF1D HsATF4 HsKLKB1 HsTUBB2 HsSPARC HsMYC 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. [19, 60] [61-63] [49, 64] [65-68] [69, 70] [71] [72] [73] [74] [75] [76] [50, 64, 77] Percy MJ, Myrie KA, Neeley CK, Azim JN, Ethier SP, Petty EM: Expression and mutational analyses of the human MAD2L1 gene in breast cancer cells. Genes Chromosomes Cancer 2000, 29(4):356-362. Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB: Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 1994, 54(2):380-385. Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y, Hortobagyi GN, Bedrosian I, Knickerbocker C, Toyofuku W, Lowe M et al: Cyclin E and survival in patients with breast cancer. N Engl J Med 2002, 347(20):15661575. Han Q, Leng J, Bian D, Mahanivong C, Carpenter KA, Pan ZK, Han J, Huang S: Rac1-MKK3-p38-MAPKAPK2 pathway promotes urokinase plasminogen activator mRNA stability in invasive breast cancer cells. J Biol Chem 2002, 277(50):48379-48385. Salh B, Marotta A, Wagey R, Sayed M, Pelech S: Dysregulation of phosphatidylinositol 3-kinase and downstream effectors in human breast cancer. Int J Cancer 2002, 98(1):148-154. Mackey JR, Jennings LL, Clarke ML, Santos CL, Dabbagh L, Vsianska M, Koski SL, Coupland RW, Baldwin SA, Young JD et al: Immunohistochemical variation of human equilibrative nucleoside transporter 1 protein in primary breast cancers. Clin Cancer Res 2002, 8(1):110-116. Decristofaro MF, Betz BL, Rorie CJ, Reisman DN, Wang W, Weissman BE: Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies. J Cell Physiol 2001, 186(1):136-145. Khatua S, Peterson KM, Brown KM, Lawlor C, Santi MR, LaFleur B, Dressman D, Stephan DA, MacDonald TJ: Overexpression of the EGFR/FKBP12/HIF2alpha pathway identified in childhood astrocytomas by angiogenesis gene profiling. Cancer Res 2003, 63(8):1865-1870. Mohler JL, Morris TL, Ford OH, 3rd, Alvey RF, Sakamoto C, Gregory CW: Identification of differentially expressed genes associated with androgen-independent growth of prostate cancer. Prostate 2002, 51(4):247-255. Fleischmann J, Kremmer E, Muller S, Sommer P, Kirchner T, Niedobitek G, Grasser FA: Expression of deoxyuridine triphosphatase (dUTPase) in colorectal tumours. Int J Cancer 1999, 84(6):614-617. Ender B, Lynch P, Kim YH, Inamdar NV, Cleary KR, Frazier ML: Overexpression of an elongation factor-1 gamma-hybridizing RNA in colorectal adenomas. Mol Carcinog 1993, 7(1):18-20. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. 24. 25. Miyaki M, Iijima T, Shiba K, Aki T, Kita Y, Yasuno M, Mori T, Kuroki T, Iwama T: Alterations of repeated sequences in 5' upstream and coding regions in colorectal tumors from patients with hereditary nonpolyposis colorectal cancer and Turcot syndrome. Oncogene 2001, 20(37):52155218. Li SR, Gyselman VG, Dorudi S, Bustin SA: Elevated levels of RanBP7 mRNA in colorectal carcinoma are associated with increased proliferation and are similar to the transcription pattern of the protooncogene c-myc. Biochem Biophys Res Commun 2000, 271(2):537-543. Kao J, Houck K, Fan Y, Haehnel I, Libutti SK, Kayton ML, Grikscheit T, Chabot J, Nowygrod R, Greenberg S et al: Characterization of a novel tumorderived cytokine. Endothelial-monocyte activating polypeptide II. J Biol Chem 1994, 269(40):25106-25119. Berger AC, Tang G, Alexander HR, Libutti SK: Endothelial monocyteactivating polypeptide II, a tumor-derived cytokine that plays an important role in inflammation, apoptosis, and angiogenesis. J Immunother 2000, 23(5):519-527. Grabsch H, Takeno S, Parsons WJ, Pomjanski N, Boecking A, Gabbert HE, Mueller W: Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer--association with tumour cell proliferation. J Pathol 2003, 200(1):16-22. You C, Xu X, Cal B, Zhang S: [Expression and implication of c-myb and bcl-2 proteins in C6 gliomas]. Hua Xi Yi Ke Da Xue Xue Bao 2000, 31(3):304-305, 318. Yokota S, Yamamoto Y, Shimizu K, Momoi H, Kamikawa T, Yamaoka Y, Yanagi H, Yura T, Kubota H: Increased expression of cytosolic chaperonin CCT in human hepatocellular and colonic carcinoma. Cell Stress Chaperones 2001, 6(4):345-350. Qin LX, Tang ZY: The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol 2002, 8(3):385-392. Lim SO, Park SJ, Kim W, Park SG, Kim HJ, Kim YI, Sohn TS, Noh JH, Jung G: Proteome analysis of hepatocellular carcinoma. Biochem Biophys Res Commun 2002, 291(4):1031-1037. Blask DE, Sauer LA, Dauchy RT, Holowachuk EW, Ruhoff MS, Kopff HS: Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events. Cancer Res 1999, 59(18):4693-4701. Lundquist A, Barre B, Bienvenu F, Hermann J, Avril S, Coqueret O: Kaposi sarcoma-associated viral cyclin K overrides cell growth inhibition mediated by oncostatin M through STAT3 inhibition. Blood 2003, 101(10):4070-4077. Vazquez-Abad D, Carson JH, Rothfield N: Localization of histidyl-tRNA synthetase (Jo-1) in human laryngeal epithelial carcinoma cell line (HEp2 cells). Cell Tissue Res 1996, 286(3):487-491. Wang J, Zhou Y, Yin B, Du G, Huang X, Li G, Shen Y, Yuan J, Qiang B: ASH2L: alternative splicing and downregulation during induced megakaryocytic differentiation of multipotential leukemia cell lines. J Mol Med 2001, 79(7):399-405. Kanno T, Endo H, Takeuchi K, Morishita Y, Fukayama M, Mori S: High expression of methionine aminopeptidase type 2 in germinal center B cells and their neoplastic counterparts. Lab Invest 2002, 82(7):893-901. 26. 27. 28. 29. 30. 31. 32. 33. 34. 35. 36. 37. 38. 39. 40. Wang WS, Chen PM, Hsiao HL, Ju SY, Su Y: Overexpression of the thymosin beta-4 gene is associated with malignant progression of SW480 colon cancer cells. Oncogene 2003, 22(21):3297-3306. Hubmann R, Schwarzmeier JD, Shehata M, Hilgarth M, Duechler M, Dettke M, Berger R: Notch2 is involved in the overexpression of CD23 in B-cell chronic lymphocytic leukemia. Blood 2002, 99(10):3742-3747. Sriuranpong V, Borges MW, Ravi RK, Arnold DR, Nelkin BD, Baylin SB, Ball DW: Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res 2001, 61(7):3200-3205. Poetsch M, Dittberner T, Cowell JK, Woenckhaus C: TTC4, a novel candidate tumor suppressor gene at 1p31 is often mutated in malignant melanoma of the skin. Oncogene 2000, 19(50):5817-5820. Nakamoto K, Ito A, Watabe K, Koma Y, Asada H, Yoshikawa K, Shinomura Y, Matsuzawa Y, Nojima H, Kitamura Y: Increased expression of a nucleolar Nop5/Sik family member in metastatic melanoma cells: evidence for its role in nucleolar sizing and function. Am J Pathol 2001, 159(4):1363-1374. Gaggioli C, Deckert M, Aberdam E, Ortonne JP, Ballotti R, Tartare-Deckert S: SP-05 Differential Regulation of Egr-1 by HGF/SF in Melanocytes and Melanoma cells. Pigment Cell Res 2003, 16(5):573-574. Yang SZ, Abdulkadir SA: Early growth response gene 1 modulates androgen receptor signaling in prostate carcinoma cells. J Biol Chem 2003, 278(41):39906-39911. Kinnula VL, Lehtonen S, Sormunen R, Kaarteenaho-Wiik R, Kang SW, Rhee SG, Soini Y: Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma. J Pathol 2002, 196(3):316-323. Pineault N, Buske C, Feuring-Buske M, Abramovich C, Rosten P, Hogge DE, Aplan PD, Humphries RK: Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1. Blood 2003, 101(11):4529-4538. Stone B, Schummer M, Paley PJ, Thompson L, Stewart J, Ford M, Crawford M, Urban N, O'Briant K, Nelson BH: Serologic analysis of ovarian tumor antigens reveals a bias toward antigens encoded on 17q. Int J Cancer 2003, 104(1):73-84. Li D, Zhu J, Firozi PF, Abbruzzese JL, Evans DB, Cleary K, Friess H, Sen S: Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. Clin Cancer Res 2003, 9(3):991-997. Schneider D, Kleeff J, Berberat PO, Zhu Z, Korc M, Friess H, Buchler MW: Induction and expression of betaig-h3 in pancreatic cancer cells. Biochim Biophys Acta 2002, 1588(1):1-6. Abdulkadir SA, Qu Z, Garabedian E, Song SK, Peters TJ, Svaren J, Carbone JM, Naughton CK, Catalona WJ, Ackerman JJ et al: Impaired prostate tumorigenesis in Egr1-deficient mice. Nat Med 2001, 7(1):101-107. Cornford PA, Dodson AR, Parsons KF, Desmond AD, Woolfenden A, Fordham M, Neoptolemos JP, Ke Y, Foster CS: Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res 2000, 60(24):7099-7105. Takashi M, Katsuno S, Sakata T, Ohshima S, Kato K: Different concentrations of two small stress proteins, alphaB crystallin and HSP27 in human urological tumor tissues. Urol Res 1998, 26(6):395-399. 41. 42. 43. 44. 45. 46. 47. 48. 49. 50. 51. 52. 53. 54. 55. 56. Chaib H, Cockrell EK, Rubin MA, Macoska JA: Profiling and verification of gene expression patterns in normal and malignant human prostate tissues by cDNA microarray analysis. Neoplasia 2001, 3(1):43-52. Li P, Yu X, Ge K, Melamed J, Roeder RG, Wang Z: Heterogeneous expression and functions of androgen receptor co-factors in primary prostate cancer. Am J Pathol 2002, 161(4):1467-1474. Xu K, Luduena RF: Characterization of nuclear betaII-tubulin in tumor cells: a possible novel target for taxol. Cell Motil Cytoskeleton 2002, 53(1):39-52. Li A, Zhu X, Brown B, Craft CM: Gene expression networks underlying retinoic acid-induced differentiation of human retinoblastoma cells. Invest Ophthalmol Vis Sci 2003, 44(3):996-1007. Cheng L, Sturgis EM, Eicher SA, Spitz MR, Wei Q: Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck. Cancer 2002, 94(2):393-397. Takano T, Hasegawa Y, Miyauchi A, Matsuzuka F, Yoshida H, Kuma K, Hayashi N, Nakamori S, Amino N: Quantitative analysis of osteonectin mRNA in thyroid carcinomas. Endocr J 2002, 49(4):511-516. Morari EC, Leite JL, Granja F, da Assumpcao LV, Ward LS: The null genotype of glutathione s-transferase M1 and T1 locus increases the risk for thyroid cancer. Cancer Epidemiol Biomarkers Prev 2002, 11(11):14851488. Gimm O, Chi H, Dahia PL, Perren A, Hinze R, Komminoth P, Dralle H, Reynolds PR, Eng C: Somatic mutation and germline variants of MINPP1, a phosphatase gene located in proximity to PTEN on 10q23.3, in follicular thyroid carcinomas. J Clin Endocrinol Metab 2001, 86(4):1801-1805. Hashimoto K, Azuma C, Tokugawa Y, Nobunaga T, Aki TA, Matsui Y, Yanagida T, Izumi H, Saji F, Murata Y: Loss of H19 imprinting and upregulation of H19 and SNRPN in a case with malignant mixed Mullerian tumor of the uterus. Hum Pathol 1997, 28(7):862-865. Karlsson A, Helou K, Walentinsson A, Hedrich HJ, Szpirer C, Levan G: Amplification of Mycn, Ddx1, Rrm2, and Odc1 in rat uterine endometrial carcinomas. Genes Chromosomes Cancer 2001, 31(4):345-356. Ishimi Y, Okayasu I, Kato C, Kwon HJ, Kimura H, Yamada K, Song SY: Enhanced expression of Mcm proteins in cancer cells derived from uterine cervix. Eur J Biochem 2003, 270(6):1089-1101. Holtrich U, Wolf G, Brauninger A, Karn T, Bohme B, Rubsamen-Waigmann H, Strebhardt K: Induction and down-regulation of PLK, a human serine/threonine kinase expressed in proliferating cells and tumors. Proc Natl Acad Sci U S A 1994, 91(5):1736-1740. Yam CH, Fung TK, Poon RY: Cyclin A in cell cycle control and cancer. Cell Mol Life Sci 2002, 59(8):1317-1326. Chen HM, Yen-Ping Kuo M, Lin KH, Lin CY, Chiang CP: Expression of cyclin A is related to progression of oral squamous cell carcinoma in Taiwan. Oral Oncol 2003, 39(5):476-482. Nguyen DC, Parsa B, Close A, Magnusson B, Crowe DL, Sinha UK: Overexpression of cell cycle regulatory proteins correlates with advanced tumor stage in head and neck squamous cell carcinomas. Int J Oncol 2003, 22(6):1285-1290. Shih HC, Shiozawa T, Kato K, Imai T, Miyamoto T, Uchikawa J, Nikaido T, Konishi I: Immunohistochemical expression of cyclins, cyclin-dependent 57. 58. 59. 60. 61. 62. 63. 64. 65. 66. 67. 68. 69. 70. kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator. Hum Pathol 2003, 34(5):471-478. Todorov IT, Werness BA, Wang HQ, Buddharaju LN, Todorova PD, Slocum HK, Brooks JS, Huberman JA: HsMCM2/BM28: a novel proliferation marker for human tumors and normal tissues. Lab Invest 1998, 78(1):73-78. Hansen GM, Justice MJ: Activation of Hex and mEg5 by retroviral insertion may contribute to mouse B-cell leukemia. Oncogene 1999, 18(47):6531-6539. Kaiser A, Brembeck FH, Nicke B, Wiedenmann B, Riecken EO, Rosewicz S: All-trans-retinoic acid-mediated growth inhibition involves inhibition of human kinesin-related protein HsEg5. J Biol Chem 1999, 274(27):1892518931. Nikitakis NG, Lopes MA, Bailey JS, Blanchaert RH, Jr., Ord RA, Sauk JJ: Oral leiomyosarcoma: review of the literature and report of two cases with assessment of the prognostic and diagnostic significance of immunohistochemical and molecular markers. Oral Oncol 2002, 38(2):201208. Harper JW: Protein destruction: adapting roles for Cks proteins. Curr Biol 2001, 11(11):R431-435. Shigemasa K, Gu L, O'Brien TJ, Ohama K: Skp2 overexpression is a prognostic factor in patients with ovarian adenocarcinoma. Clin Cancer Res 2003, 9(5):1756-1763. Penin RM, Fernandez-Figueras MT, Puig L, Rex J, Ferrandiz C, Ariza A: Over-expression of p45(SKP2) in Kaposi's sarcoma correlates with higher tumor stage and extracutaneous involvement but is not directly related to p27(KIP1) down-regulation. Mod Pathol 2002, 15(11):1227-1235. Soldani C, Bottone MG, Biggiogera M, Alpini C, Scovassi AI, Martin T, Pellicciari C: Nuclear localization of phosphorylated c-Myc protein in human tumor cells. Eur J Histochem 2002, 46(4):377-380. Reis-Filho JS, Torio B, Albergaria A, Schmitt FC: p63 expression in normal skin and usual cutaneous carcinomas. J Cutan Pathol 2002, 29(9):517-523. Pelosi G, Pasini F, Olsen Stenholm C, Pastorino U, Maisonneuve P, Sonzogni A, Maffini F, Pruneri G, Fraggetta F, Cavallon A et al: p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas? J Pathol 2002, 198(1):100-109. Kaufmann O, Fietze E, Mengs J, Dietel M: Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol 2001, 116(6):823-830. Di Como CJ, Urist MJ, Babayan I, Drobnjak M, Hedvat CV, Teruya-Feldstein J, Pohar K, Hoos A, Cordon-Cardo C: p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 2002, 8(2):494-501. Yasuda M, Takesue F, Inutsuka S, Honda M, Nozoe T, Korenaga D: Overexpression of cyclin B1 in gastric cancer and its clinicopathological significance: an immunohistological study. J Cancer Res Clin Oncol 2002, 128(8):412-416. Hassan KA, Ang KK, El-Naggar AK, Story MD, Lee JI, Liu D, Hong WK, Mao L: Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma. Cancer Res 2002, 62(22):6414-6417. 71. 72. 73. 74. 75. 76. 77. Bartkova J, Zemanova M, Bartek J: Expression of CDK7/CAK in normal and tumor cells of diverse histogenesis, cell-cycle position and differentiation. Int J Cancer 1996, 66(6):732-737. Kolettas E, Lymboura M, Khazaie K, Luqmani Y: Modulation of elongation factor-1 delta (EF-1 delta) expression by oncogenes in human epithelial cells. Anticancer Res 1998, 18(1A):385-392. Bowers AJ, Scully S, Boylan JF: SKIP3, a novel Drosophila tribbles ortholog, is overexpressed in human tumors and is regulated by hypoxia. Oncogene 2003, 22(18):2823-2835. Rae F, Bulmer B, Nicol D, Clements J: The human tissue kallikreins (KLKs 1-3) and a novel KLK1 mRNA transcript are expressed in a renal cell carcinoma cDNA library. Immunopharmacology 1999, 45(1-3):83-88. Gapany M, Faust RA, Tawfic S, Davis A, Adams GL, Ahmed K: Association of elevated protein kinase CK2 activity with aggressive behavior of squamous cell carcinoma of the head and neck. Mol Med 1995, 1(6):659666. Bradshaw AD, Sage EH: SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 2001, 107(9):1049-1054. Pelengaris S, Khan M, Evan G: c-MYC: more than just a matter of life and death. Nat Rev Cancer 2002, 2(10):764-776.